Tag: venture capital

Madison Tech: Opportunity to Recycle?

An interesting question that came up at the Spring Tech Kickoff last week: what tech success stories have there been in Madison? It is immediately clear that good financial returns for tech investors are important for continued enthusiasm for investment. However, another large factor in success stories is how/whether experienced management is recycled in the

Read More

Biotech Venture Capital – EOY2012

A challenge with data is that the collection methods are critical when you are comparing data from different sources. Over at lifescivc.com, Bruce Booth of Atlas Venture recently referenced 2012 year end numbers for biotech venture capital investment from BioCentury: $5.5 Billion was invested in 2012, up from 2008-2011. Over the last couple of years, I’ve

Read More

Investing in Long Distance Relationships in Wisconsin

In my previous post about 2012 investment capital in Wisconsin, I asserted and supported the following two statements: Wisconsin has a good environment and the capital to seed and grow companies. The state lacks the in-state capital to take companies through the full funding cycle. In this post, I’m moving to the potential takeaways from

Read More

2012 Wisconsin Investment Capital Roundup

The fourth quarter venture capital investment numbers came out, which prompted me to update the biotech investment numbers as well as the Wisconsin VC numbers. As I was looking at the data, I was reminded that for a place with few VC dollars such as Wisconsin (<$100M per year across industries) we need to evaluate

Read More

Active Life Science VCs & Twitter: Correlation? Causation? Randomness?

What happens when you combine a crowdsourcing effort to identify active life science venture capital funds and add a couple of biotech entrepreneurs active in social media? In this case: a spreadsheet and a blog post. Crowdsourcing Data In the fall, there was a discussion on Twitter about the importance of life science entrepreneurs understanding

Read More

What Comes Next in Biotech Translational Capital?

Over the first half of 2012, there has been a lot of data and news about how the venture capital industry is doing. I’ve written a few drafts of a post on the topic from a biotech perspective but each one has fallen flat because in my opinion the problems in biotech VC land are

Read More

The Quarter is Over…And of course that means VC data

The venture capital investment numbers are out for the Q2 2012 (courtesy of NVCA & PwC). Last quarter, I pondered what the quarterly numbers mean relative to annual figures and I wanted to provide an update. I aim to post again about why I think the focus on these numbers distract from a more important issue: understanding how

Read More

What do quarterly VC numbers tell us?

The venture capital investment numbers are out for the first quarter of 2012 (courtesy of NVCA & PwC). Most of the reports I have seen compare the quarter to either first or fourth quarter of 2011. Either way, VC investment is down (in dollars: 13% from Q1 ’11 and 19% from Q4 ’12). Michael Greeley,

Read More

Venture Capital in Wisconsin – There Is Good News

This post started as an email to a group of friends who encouraged me to post the data, which I was prepared to ignore since I had something else in mind for this week. Then I read a post by Bruce Booth from Atlas Venture about the early stage biotech funding environment reflecting optimism that

Read More

Private Equity – Beyond Traditional Venture Capital

In the biotech industry, there is a quote by that is often used to emphasize the importance of data in decision making: “In God we trust; all others must bring data.” The quote comes from W. Edwards Deming, who had a background in statistics that he used extensively in his teachings about management. While data is important,

Read More